HT
CTXR icon

HAP Trading’s Citius Pharmaceuticals CTXR Stock Holding History

HAP Trading’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,344
Closed -$4K – 1590
2022
Q3 		$4K Buy
+1,344
New +$36.9K ﹤0.01% 1479
2022
Q2 		– Sell
-1,352
Closed -$3K – 2012
2022
Q1 		$3K Sell
1,352
-5,320
-80% -$210K ﹤0.01% 2015
2021
Q4 		$17K Buy
6,672
+4,644
+229% +$211K ﹤0.01% 1866
2021
Q3 		$14K Buy
+2,028
New +$102K ﹤0.01% 1906

Other funds holding CTXR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return